| Serial Number | 88356940 |
| Word Mark | EMPOWER YOURSELF |
| Filing Date | Tuesday, March 26, 2019 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Friday, August 4, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceutical preparations, namely, nonsteroidal anti-inflammatory drugs (NSAIDs), ibuprofen, naproxen sodium, acetaminophen, cold, sore throat and cough medications, guaifenesin, liquid cough medicines with dextromethorphan, decongestant nasal sprays, pseudoephedrine, phenylephrine, allergy medications, antihistamine pills and liquids, diphenhydramine, chlorpheniramine, brompheniramine, loratadine, fexofenadine, cetirizine, stomach upset medications, antidiarrhea medicines, loperamide, bismuth, nausea and vomiting, motion sickness, dimenhydrinate; cannabidiol (CBD) which is synthetically derived with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis for medical purposes; cannabidiol (CBD) which is synthetically derived with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis for treating, reducing or improving symptoms of various conditions, namely, pain, anxiety, depression, cancer, acne, skin conditions, neuroprotection, cardiovascular health, arthritis, inflammation, autoimmune conditions, epileptic seizures, nausea, appetite, inflammatory bowel disease, and insomnia; cannabidiol (CBD) which is synthetically derived with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis for medical purposes in sublingual doses and mucous membrane doses; skin creams, ointments, tablets, capsules, gummies, suppositories, skin patches, extended release tablets and liquids for therapeutic purposes containing cannabidiol (CBD) which is synthetically derived with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; herbal supplements containing cannabidiol (CBD) which is synthetically derived with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Liquid nutritional supplements containing cannabidiol (CBD) which is synthetically derived with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis for treating, reducing or improving symptoms of various conditions, namely, pain, anxiety, depression, cancer, acne, skin conditions, neuroprotection, cardiovascular health, arthritis, inflammation, autoimmune conditions, epileptic seizures, nausea, appetite, inflammatory bowel disease, and insomnia |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, April 11, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | EmpowerPharm Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Burlington, Ontario L7L6M1 CA |
| Event Date | Event Description |
| Friday, August 4, 2023 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Friday, August 4, 2023 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Friday, August 4, 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Wednesday, April 12, 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Wednesday, April 12, 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Friday, January 20, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, January 20, 2023 | NON-FINAL ACTION E-MAILED |
| Friday, January 20, 2023 | NON-FINAL ACTION WRITTEN |
| Thursday, December 22, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, December 22, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, December 20, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Tuesday, December 20, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, December 20, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, December 20, 2022 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Thursday, July 28, 2022 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Thursday, July 28, 2022 | INQUIRY TO SUSPENSION E-MAILED |
| Thursday, July 28, 2022 | SUSPENSION INQUIRY WRITTEN |
| Monday, July 18, 2022 | SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION |
| Tuesday, January 11, 2022 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Tuesday, January 11, 2022 | LETTER OF SUSPENSION E-MAILED |
| Tuesday, January 11, 2022 | SUSPENSION LETTER WRITTEN |
| Tuesday, January 11, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, January 11, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, January 11, 2022 | ASSIGNED TO LIE |
| Friday, January 7, 2022 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Friday, July 9, 2021 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Friday, July 9, 2021 | INQUIRY TO SUSPENSION E-MAILED |
| Friday, July 9, 2021 | SUSPENSION INQUIRY WRITTEN |
| Thursday, July 8, 2021 | SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION |
| Wednesday, August 12, 2020 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Wednesday, August 12, 2020 | LETTER OF SUSPENSION E-MAILED |
| Wednesday, August 12, 2020 | SUSPENSION LETTER WRITTEN |
| Tuesday, July 21, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, July 21, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, July 21, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, January 21, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, January 21, 2020 | NON-FINAL ACTION E-MAILED |
| Tuesday, January 21, 2020 | NON-FINAL ACTION WRITTEN |
| Tuesday, January 14, 2020 | ASSIGNED TO EXAMINER |
| Monday, April 15, 2019 | ASSIGNED TO EXAMINER |
| Thursday, April 11, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, March 29, 2019 | NEW APPLICATION ENTERED |